Mission
To create a unique multidisciplinary group to foster a collaborative environment between researchers and clinicians who are interested in the field of cardio-oncology (cardiotoxicity of anticancer therapies) to improve the outcomes of cancer patients.
The objectives of this working group are to advance cardio-oncology through basic and translational research and to foster early-career investigators.
Current areas of interest include:
- Anthracycline-induced cardiomyopathy
- Proteasome inhibitor-related cardiotoxicity
- Radiation therapy-related cardiotoxicity
- Immune checkpoint inhibitor-related cardiotoxicities
- Exercise intervention in cancer patients
- Disparities in cardiotoxicity in cancer patients
- Cardioprotective agents
- Genetics of cardio-oncology
Meeting agenda items will vary and can include:
- Presenting results of studies
- Presentation and discussion of recent publications in the field
- Identification of collaborators
- Discussion to create additional collaborative grant applications
- Presentation of early-stage ideas for feedback
- Discussion to help strengthen proposals before submission to funding agencies
- Presentation by an outside expert
Chairs
For more information about the group, please contact co-chairs Katelyn A. Bruno, Ph.D., FHFSA, or Yan Gong, Ph.D.
Katelyn A Bruno PhD, FHFSA, FACC
Working Group Committee
Demetra Christou, Ph.D., FAHA
Associate Professor, Department of Applied Physiology & Kinesiology, UF College of Health and Human Performance
Phone: 352-294-1715
Email: ddchristou@ufl.edu
Walter O’Dell, Ph.D.
Associate Professor, Department of Radiation Oncology, UF College of Biomedical Engineering and Medical Physics
Phone: 352-265-7834
Email: ODELWG@shands.ufl.edu
Ashley Smuder, Ph.D.
Assistant Professor, Department of Applied Physiology & Kinesiology, UF College of Health & Human Performance
Phone: 352-294-1765
Email: asmuder@ufl.edu
Jennifer Woodard, M.P.H., CCRP
Director, Office of Community Outreach & Engagement, UF Health Cancer Institute
Associate Director, Clinical Research, Department of Health Outcomes and Biomedical Informatics
Phone: 352-294-5974
Email: jenwoodard@ufl.edu
Register
If you would like to become a member of the Cardio-Oncology working group, please register.
Cardio-Oncology Related Funding Opportunities
| Title | Organization | Keywords | Activity Code | FOA | LOI Due Date | Application Due Date | Rollover | Repost | Status |
|---|---|---|---|---|---|---|---|---|---|
| Translational Research Grants | International Waldenstrom's Macroglobulinemia Foundation (IWMF) | OAFS, cellular vulnerabilities, resistance, preclinical, novel, immunotherapy, molecular pathways, therapeutic, preclinical | 11/28/2025 | 2/27/2026 | Open | ||||
| International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Award | International Myeloma Society | OAFS, translational, myeloma, plasma cell, translational, myeloma, early detection, diagnosis, treatment, biochemical, biomarker, therapeutic | 1/30/2026 | Open | |||||
| New Investigator Research Grant Program | Leukemia Research Foundation | OAFS, Leukemia, Lymphoma, Translational Research, early-stage, ESI | 2/6/2026 | 4/13/2026 | Open | ||||
| Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) | National Institutes of Health | shared resources, clinical, protocol development, advanced imaging, biomarker validation, translational, multidisciplinary | U01 | PAR-26-116 | 2/5/2026 | Open | |||
| Translational Research Grants | National Psoriasis Foundation | OAFS, bench to bedside, therapeutic, biomarker development, clinical | 1/30/2026 | Open |
